[
    "{\"step_by_step_thinking\": \"The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is not effective in children under 2 years of age, so option C is incorrect. The vaccine is recommended for adults and children over 2 years of age who are at high risk of pneumococcal disease, including those with sickle cell disease, so option D is correct. While the vaccine may also be beneficial for individuals with cystic fibrosis or those experiencing recurrent otitis media and sinusitis, the question asks for the most useful application, which would be in individuals with sickle cell disease due to their increased risk of severe pneumococcal infections.\", \"answer_choice\": \"D\"}"
]